Clinical Trials Browser

Phase 4 × Breast Neoplasms × Letrozole × Clear all

NCT05161195 2026-02-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

Breast Neoplasms

NCT02661932 2025-01-31

Brovale

Phase 4 Completed

Breast Neoplasms

NCT03948568 2022-09-30

REaCT-RETT

Phase 4 Completed

Breast Neoplasms

NCT02679755 2022-07-27

Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer

Phase 4 Completed

252 enrolled 15 charts

Breast Neoplasms

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT04137640 2021-07-20

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Phase 4 Not yet recruiting

Breast Neoplasms

NCT00688909 2021-06-09

REAL

Phase 4 Completed

261 enrolled 13 charts

Breast Neoplasms

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms

NCT01612871 2018-03-05

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT01127295 2018-03-02

PHACS

Phase 4 Completed

Breast Neoplasms

NCT00237133 2017-02-24

PREDICT

Phase 4 Completed

Breast Neoplasms

NCT01553903 2013-06-04

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT00014638 2013-02-21

Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 4 Completed

Breast Neoplasms

NCT00241046 2012-04-19

Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment

Phase 4 Terminated

Breast Neoplasms

NCT00171847 2010-03-31

eLEcTRA

Phase 4 Terminated

Breast Neoplasms, Neoplasm Metastasis

NCT00237224 2009-11-19

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

Phase 4 Completed

Breast Neoplasms